IGF1 and hepatocellular carcinoma: HCC patients of Child–Pugh class C (p = 0.002), Barcelona Clinic Liver Cancer Stage-B (BCLC-B) (p < 0.01), or BCLC-C (p = 0.019) had significantly lower baseline IGF1 levels.